At Akesa, we recognise that orchestrating a clinical supply chain for a biosimilar trial is far from a routine endeavour. These trials present distinct challenges that demand specialised expertise from clinical supply chain professionals.
One of the key distinctions lies in the procurement of the comparator medication. A strategic sourcing approach is essential because these trials frequently focus on biologic medications, known for their considerable cost and high demand.
As a leading sourcing company, we take pride in our collaborative partnerships with – pharmaceutical, biotech, and CRO organisations to supporting biosimilar clinical trials. Leveraging our extensive expertise, we craft and execute unparalleled supply solutions.
Our unwavering commitment to excellence drives us to establish the most effective clinical trial supply strategies, ultimately contributing to the success of our sponsors.
Working with you on a strategic sourcing strategy for your biosimilar drug trial
We are dedicated to partnering with you to develop a strategic sourcing strategy tailored specifically to your biosimilar drug trial. We understand that the success of your clinical trial hinges on an efficient and dependable supply chain.
Our commitment begins with an assessment of your trial’s unique requirements, considering the nuances of biosimilar trials, which often involve high-cost biologic medicines in great demand. We recognise that the sourcing of comparator medications is a critical aspect, and we work closely with you to devise a strategy that ensures a seamless supply of these vital components.
Our aim is to provide you with the product required, enabling you to conduct your trial with confidence and precision.
Developing a sourcing strategy that works for your organisation
We are dedicated to partnering with you to develop a strategic sourcing strategy tailored specifically to your biosimilar drug trial. We understand that the success of your clinical trial hinges on an efficient and dependable supply chain.
When you choose Akesa, you choose a partner committed to your success, dedicated to streamlining your clinical supply chain, and focused on helping you achieve your research goals with excellence.
Akesa builds strong supplier relationships to support sponsors with an integrated sourcing and supply chain solution
At Akesa, we recognise that orchestrating a clinical supply chain for a biosimilar trial is far from a routine endeavour. These trials present distinct challenges that demand specialised expertise from clinical supply chain professionals.
One of the key distinctions lies in the procurement of the comparator medication. A strategic sourcing approach is essential because these trials frequently focus on biologic medications, known for their considerable cost and high demand.
As a leading sourcing company, we take pride in our collaborative partnerships with – pharmaceutical, biotech, and CRO organisations to supporting biosimilar clinical trials. Leveraging our extensive expertise, we craft and execute unparalleled supply solutions.
Our unwavering commitment to excellence drives us to establish the most effective clinical trial supply strategies, ultimately contributing to the success of our sponsors.
Developing strategic sourCing options for comparator supplies in biosimilar drug trial
Direct sourcing – sourcing from the manufacturer
Direct sourcing offers numerous advantages that are invaluable in the context of clinical trials. It provides the safest and shortest supply chain route, ensuring that critical trial components reach their destination swiftly and securely.
With comprehensive documentation for submission and logistics, direct sourcing streamlines the administrative aspects, minimising potential hurdles. High volumes and optimal shelf-life of sourced materials are guaranteed, facilitating the smooth execution of trials. Additionally, the possibility of offering matching placebos ensures the integrity of the trial, while price stability throughout the trial’s duration guarantees budget predictability.
Most importantly, direct sourcing eliminates the risk of supply interruptions, offering uninterrupted access to essential trial components, which is crucial for the seamless progression of clinical research.
Hybrid solution – bespoke approach to sourcing
Akesa’s hybrid solution represents a bespoke approach to sourcing that harnesses the best of both direct and open market sourcing strategies. This innovative approach allows sponsors to tailor their sourcing strategy to the unique requirements of their clinical trials. By seamlessly integrating direct sourcing, which ensures supply chain safety, full documentation, and stability, with open market sourcing, which offers flexibility in terms of lead-time and cost, sponsors can strike an ideal balance.
Our hybrid solution allows sponsors to navigate situations where Phase 1 study data must remain confidential or when the originator is unwilling to supply directly. This hybrid approach is a testament to the adaptability and versatility of modern sourcing strategies, ensuring that sponsors have the agility and discretion they need to advance their clinical research goals effectively.
Open Market – Sourcing from the wholesaler
Open market sourcing presents distinct advantages, particularly in scenarios where discretion and agility are paramount. By not disclosing Phase 1 study data, sponsors can safeguard sensitive information, preserving their competitive edge. The short lead-time associated with open market sourcing ensures rapid acquisition of trial components, enabling quicker trial initiation.
Price flexibility is another key benefit, allowing sponsors to explore cost-effective options that align with their budget constraints. In cases where the originator is unwilling to supply directly, open market sourcing becomes a pragmatic solution, offering access to essential trial materials while maintaining necessary discretion and flexibility.
Let Discovery Live with Akesa
Partner with Akesa for a reliable and consistent supply of pharmaceutical products, and dedicated support for your biosimilar clinical trial. Let us help you navigate the complexities of commercial supply, mitigate potential risks, and ensure that your trial runs smoothly from start to finish. Contact us today to learn how we can support your drug development journey.
